Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$670M
| $5.85M | ﹤0.01% |
15,735
-4,305
| -21% | -$1.59M |
|
3677
Brunswick
BC
$4.97B
| $5.84M | ﹤0.01% |
58,641
+52,537
| +861% | +$5.35M |
|
|
COOP
3678
DELISTED
Mr. Cooper
COOP
| $5.84M | ﹤0.01% |
176,664
+115,266
| +188% | +$3.85M |
|
3679
PUT
Fate Therapeutics
FATE
$291M
| $5.84M | ﹤0.01% |
67,300
-48,700
| -42% | -$3.92M |
|
3680
CALL
Western Midstream Partners
WES
$20B
| $5.84M | ﹤0.01% |
272,600
-33,100
| -11% | -$686K |
|
3681
Ametek
AME
$54.2B
| $5.83M | ﹤0.01% |
43,706
+9,955
| +29% | +$1.33M |
|
3682
Oceaneering
OII
$5.04B
| $5.83M | ﹤0.01% |
374,797
+299,119
| +395% | +$4.17M |
|
3683
CALL
Leidos
LDOS
$17.7B
| $5.83M | ﹤0.01% |
57,700
-31,000
| -35% | -$3.18M |
|
3684
CALL
Schwab US Dividend Equity ETF
SCHD
$111B
| $5.83M | ﹤0.01% |
231,300
-102,000
| -31% | -$2.58M |
|
3685
CALL
Arvinas
ARVN
$600M
| $5.83M | ﹤0.01% |
75,700
-6,100
| -7% | -$423K |
|
3686
PUT
Entegris
ENTG
$20.6B
| $5.83M | ﹤0.01% |
47,400
+21,300
| +82% | +$2.45M |
|
|
GBT
3687
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.83M | ﹤0.01% |
166,404
+42,376
| +34% | +$1.65M |
|
3688
Xylem
XYL
$26B
| $5.82M | ﹤0.01% |
48,552
+20,817
| +75% | +$2.38M |
|
3689
Cemex
CX
$15.7B
| $5.82M | ﹤0.01% |
692,650
-455,460
| -40% | -$3.62M |
|
3690
Loews
L
$22.4B
| $5.82M | ﹤0.01% |
106,465
+24,298
| +30% | +$1.36M |
|
|
ACIC
3691
PUT
DELISTED
Atlas Crest Investment Corp.
ACIC
| $5.82M | ﹤0.01% |
+583,800
| New | +$5.81M |
|
3692
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$98.9M
| $5.81M | ﹤0.01% |
59,000
+41,700
| +241% | +$3.64M |
|
3693
HSBC
HSBC
$355B
| $5.81M | ﹤0.01% |
201,523
-119,418
| -37% | -$3.65M |
|
|
RUBY
3694
CALL
DELISTED
Rubius Therapeutics, Inc
RUBY
| $5.81M | ﹤0.01% |
238,000
+52,300
| +28% | +$1.31M |
|
3695
PUT
iShares MSCI Germany ETF
EWG
$1.74B
| $5.81M | ﹤0.01% |
167,800
+20,600
| +14% | +$724K |
|
3696
PUT
Dover
DOV
$26.8B
| $5.8M | ﹤0.01% |
38,500
+25,000
| +185% | +$3.69M |
|
|
HEXO
3697
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
| $5.8M | ﹤0.01% |
71,386
+165
| +0.2% | +$14.4K |
|
3698
Gogo Inc
GOGO
$369M
| $5.8M | ﹤0.01% |
509,351
-72,013
| -12% | -$833K |
|
3699
PUT
Welltower
WELL
$172B
| $5.79M | ﹤0.01% |
69,700
-19,500
| -22% | -$1.49M |
|
|
SRAX
3700
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
| $5.79M | ﹤0.01% |
1,064,121
+610,553
| +135% | +$2.94M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.